HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Man Chu Selected Research

san miao san

1/2022Elucidation of Potential Targets of San-Miao-San in the Treatment of Osteoarthritis Based on Network Pharmacology and Molecular Docking Analysis.
1/2021Lingzhi and San-Miao-San with hyaluronic acid gel mitigate cartilage degeneration in anterior cruciate ligament transection induced osteoarthritis.
1/2016Anti-inflammatory activities of Ganoderma lucidum (Lingzhi) and San-Miao-San supplements in MRL/lpr mice for the treatment of systemic lupus erythematosus.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Man Chu Research Topics

Disease

9Neoplasms (Cancer)
10/2022 - 01/2020
6Carcinogenesis
01/2022 - 01/2020
3Inflammation (Inflammations)
12/2017 - 01/2016
2Neoplasm Metastasis (Metastasis)
01/2022 - 01/2021
2Osteoarthritis
01/2022 - 01/2021
2Asthma (Bronchial Asthma)
12/2017 - 07/2016
2Systemic Lupus Erythematosus (Libman-Sacks Disease)
01/2016 - 10/2015
1Pancreatic Neoplasms (Pancreatic Cancer)
01/2022
1Pathologic Processes
01/2022
1Uterine Cervical Neoplasms (Cancer of the Cervix)
09/2021
1Prostatic Neoplasms (Prostate Cancer)
01/2021
1Kidney Neoplasms (Kidney Cancer)
06/2020
1Respiratory Hypersensitivity
12/2017
1Nephritis
01/2017
1Proteinuria
01/2017
1Arthralgia (Joint Pain)
01/2016
1Atopic Dermatitis (Atopic Eczema)
01/2016

Drug/Important Bio-Agent (IBA)

3san miao sanIBA
01/2022 - 01/2016
3Proteins (Proteins, Gene)FDA Link
12/2020 - 01/2020
2CurcuminIBA
10/2022 - 01/2022
2ResveratrolIBA
10/2022 - 01/2022
2QuercetinIBA
10/2022 - 01/2022
2Long Noncoding RNAIBA
01/2022 - 01/2022
2CytokinesIBA
01/2017 - 07/2016
2InterleukinsIBA
07/2016 - 10/2015
13,3'-diindolylmethane (diindolylmethane)IBA
10/2022
1ApigeninIBA
10/2022
1PolyphenolsIBA
10/2022
1indole-3-carbinolIBA
10/2022
1withaferin AIBA
10/2022
1sulforaphaneIBA
10/2022
1TeaIBA
10/2022
1IsoflavonesIBA
10/2022
1Circular RNAIBA
01/2022
1salinomycinIBA
01/2022
1Biological ProductsIBA
01/2022
1Pharmaceutical PreparationsIBA
01/2022
1Biomarkers (Surrogate Marker)IBA
01/2022
1GenisteinIBA
01/2022
1MicroRNAs (MicroRNA)IBA
01/2022
1MethyltransferasesIBA
09/2021
1Cisplatin (Platino)FDA LinkGeneric
09/2021
1Ligases (Synthetase)IBA
01/2021
1VaccinesIBA
01/2021
1Immune Checkpoint InhibitorsIBA
01/2021
1Hyaluronic Acid (Hyaluronan)IBA
01/2021
1Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA
12/2020
1Protein-Lysine 6-Oxidase (Lysyl Oxidase)IBA
11/2020
1Oncogene Proteins (Oncogene Protein)IBA
06/2020
1Histone MethyltransferasesIBA
01/2020
1F-Box ProteinsIBA
01/2020
1AllergensIBA
12/2017
1OvalbuminIBA
12/2017
1CathelicidinsIBA
12/2017
1Interleukin-22 (IL-22)IBA
01/2017
1Interleukin-17 (Interleukin 17)IBA
01/2017
1LigandsIBA
01/2016
1p38 Mitogen-Activated Protein KinasesIBA
01/2016
1NF-kappa B (NF-kB)IBA
01/2016
1Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA
01/2016

Therapy/Procedure

5Therapeutics
10/2022 - 01/2020
2Immunotherapy
01/2021 - 01/2021
1Drug Therapy (Chemotherapy)
01/2021
1Intranasal Administration
12/2017
1Intravenous Administration
01/2017